Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Timothée Klopfenstein and Marc Puyraveau.
Timothée Klopfenstein
Connection Strength
0.539
Marc Puyraveau
  1. Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia. Infect Dis Ther. 2021 Sep; 10(3):1195-1213.
    View in: PubMed
    Score: 0.239
  2. Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'. Ann Rheum Dis. 2021 Jun 23.
    View in: PubMed
    Score: 0.238
  3. It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2022 02 11; 74(3):560-562.
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.